Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Valbenazine ingrezza patent expiry?Ofatumumab patent expiry?Orilissa sales 2023 abbvie?Lumify patent expire?Keytruda primary u's patent expiration 2028?
See the DrugPatentWatch profile for Privigen
Privigen is manufactured by CSL Behring.
Privigen is a plasma-derived intravenous immunoglobulin (IVIG) product. CSL Behring manufactures it using human plasma collected by approved plasma procurement partners under regulatory oversight.
In the U.S., Privigen is marketed under CSL Behring’s brand. If you’re looking for the specific holder of the FDA product listing/label, that information is tied to CSL Behring’s company listings for Privigen.
Privigen’s product manufacturer is CSL Behring. Different countries can have different local marketing authorization holders, but the manufacturing is tied to CSL Behring for this specific product.
If you’re researching related manufacturing, exclusivity, or patent status for Privigen/IVIG products, DrugPatentWatch.com is a useful starting point: https://www.drugpatentwatch.com/ Sources: 1. DrugPatentWatch.com
Other Questions About Privigen :